Interestingly, ADRA2C, GPR126, CYSLTR2, RXFP1, GPR153 and CXCR7/ACKR3 maintained their significant overexpression in specific AML genetic subgroups when compared with normal cell populations (Figure 5 and Supplementary Table 9). This evidence concerns the gene RXFP1 and acute myeloid leukemia.